Skip to main content
SpringerLink
Log in

Retroperitoneale Weichteiltumoren

  • Chapter
  • First Online:
Uroonkologie

  • 2861 Accesses

Zusammenfassung

Primäre retroperitoneale Weichteiltumoren sind seltene Tumoren. Rund 60–80% der primären retroperitonealen Tumoren sind maligne, wobei die Sarkome einen Großteil dieser Malignome ausmachen. Zu den organgebundenen retroperitonealen Tumoren gehören die Tumoren der Niere, der Nebenniere, des Ureters und des Pankreas. Dieser Beitrag behandelt die retroperitonealen Weichteiltumoren unter den Aspekten onkologische Kennzeichen, Diagnostik, Therapie, Nachsorge und Prognose.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Aletkiar KM, Hu K, Anderson L. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2000; 47: 157–163

    Article  Google Scholar 

  • Alvegard TA, Berg NO. Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol 1989; 7: 1845–1851

    PubMed  CAS  Google Scholar 

  • Artandi SE, Chang S, Lee SL, Alson G, Gottlieb GJ, Chin L, DePinho R. A telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (Lond.) 2000; 406: 641–645

    Article  CAS  Google Scholar 

  • Barken D, Wright E, Nguyen D: Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region for chromosome 17. Science 1987; 236: 1100

    Article  Google Scholar 

  • Bengmark S, Haftström L, Jönsson PE, Karp W, Nordgren H. Retroperitoneal sarcoma treatment by surgery. J Surg Oncol 1980; 14: 307–314

    Article  PubMed  CAS  Google Scholar 

  • Bennicelli JL, Barr FG. Chromosomal translocations and sarcomas. Curr Opin Oncol 2002; 14: 412–419

    Article  PubMed  CAS  Google Scholar 

  • Berquist TH, Ehman RL, King BF, Hodgman CG, Ilstrup DM, Value of MR imaging in differentiating benign from malignant soft tissue masses: study of 95 lesions. Am J Roentgenol 1990: 155: 1251–1255

    Article  CAS  Google Scholar 

  • Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, Fletcher CD, Fletcher J; Ladanyi M, Meltzer P, O´Sullivan B, Parkinson DR, Pisters P, Saxman A, Siner S, Sundaram M, Oosterom AT, Verweij J, Waalen J, Weiss SW, Brennan MF. Soft tissue sarcomas of the adults: state of the translational science. Clin Canc Res 2003; 9: 1941–1956

    Google Scholar 

  • Brady MS, Gaynor JJ, Brennan MF. Radiation associated syrcoma of bone and soft tissue. Arch Surg 1992; 127: 1379

    Article  PubMed  CAS  Google Scholar 

  • Bramwell VH, Anderson D, Charette ML. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guidelines. Sarcoma 2000; 4: 103–112

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Brennan MF. Staging for soft tissue sarcoma. Ann Surg Oncol 1999; 6: 8–9

    Google Scholar 

  • Brin EN, Schiff M, Weiss RM. Palliative Urinary diversion for pelvic malignancy. J Urol 1975; 113: 619–622

    PubMed  CAS  Google Scholar 

  • Brown FM, Fletcher CD. Problems in grading soft tissue sarcomas. Am J Clin Pathol 2000; 114 (Suppl): 882

    Google Scholar 

  • Buchdunger E, Cioffi C, Law N, Stoyer D, Ohno-Jones S, Druker BJ, Lydon NB. Abl protein-tyrosine kinase inhibitor STI 571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139–145

    PubMed  CAS  Google Scholar 

  • Bui NB, Dermaille MC, Chevreau C, Blay JY, Cupissol D, Rios M, Thyss A, Maugard C, Bastit P, Blay JO, Tanguy A, Fargeot P, Lortholary A, Bonichon F. qMAID vs. MAID + 25 % with G-CSF in adults with advanced soft tissue sarcomas (STS). First results of a randomzied study of the FNCLCC Sarcoma group. Prog Proc Am Soc Clin Oncol 1998; 17: 517

    Google Scholar 

  • Catton CN, O‘Sullivan B, Kottwall et al. Outcome and prognosis in retroperitoneal sof tissue sarcoma. Int J Radiat Oncol Biol Phys 1994; 29: 1005–1010

    Google Scholar 

  • Cho SY, Moon KC; Cheong MS; Kwak C; Kim HH, Ku JH. Significance of microscopic margin status in completely resected retroperitoneal sarcoma. J Urol 2011; 186: 59–65

    Article  PubMed  Google Scholar 

  • Coindre JM, Terrier P, Guillou L et al. Predictive value of grade for metastasisdevelopment in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914–1926

    Article  PubMed  CAS  Google Scholar 

  • Cornier JN, Pollock RE. Soft tissue sarcomas. Cancer J Clin 2004; 54: 94–109

    Article  Google Scholar 

  • Crim JR, Seeger LL, Yao l, Chandnani B, Eckardt JJ. Diagnosis of soft tissue masses with MR imaging: can benign masses be differentiated from malignant ones. Radiology 1992; 185: 581–586

    PubMed  CAS  Google Scholar 

  • Dalton RR, Donohue JH, Mucha P, et al. Management of retroperitoneal sarcomas. Surgery 1989; 106: 725–733

    PubMed  CAS  Google Scholar 

  • de Saint Aubain Somerhausen N, Fletcher CD. Soft-tissue sarcomas: an update. Eur J Surg Oncol 1999; 25: 215–220

    Article  PubMed  Google Scholar 

  • Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472–480

    Article  PubMed  CAS  Google Scholar 

  • Druker BJ, Tamura S, Buchdunger e, Ohmo S, Segal GM, Fanning S, Zimmermann J, Lydon NB. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2: 561–566

    Article  PubMed  CAS  Google Scholar 

  • Druker B, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohmo-Jones S, Sawyers CL. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037

    Article  PubMed  CAS  Google Scholar 

  • Dupuy DF, Rosenberg AE, Punyaratabandhu T. Accuracy of CT-guided needle biosy of musculoskeletal neoplasms. Am J Roentgenol 1998; 171: 759–762

    Article  CAS  Google Scholar 

  • Dutrillaux B. Caryotype, vieillissement et types de cancer : y a-t-il un lien ? Bull Cancer (Paris) 2000; 87: 19–23

    Google Scholar 

  • Edmonson JH, Ryan LM, Blum RH, Brooks JS; Shiraki M, Frytak S, Parkinson DR. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcoma. J Clin Oncol 1993; 11: 1269–1275

    PubMed  CAS  Google Scholar 

  • Eilber FC, Brennan MF, Eilber FR, Dry SM, Singer S, Kattan MW. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 2004; 101: 2270–2275

    Article  PubMed  Google Scholar 

  • Fletcher CD, Unni KK, Mertens F. Pathology and genetics of tumors of soft tissue and bone. In Kleinhues P, Sobin LH (eds) World Health Organization Classification of tumors, vol 1 Lyon, IARC Press, 2002

    Google Scholar 

  • Fong Y, Coit DG, Woodruff J, Shi W, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993; 218: 72–77

    Article  Google Scholar 

  • Gibault K, Perot G, Chibon F, Bonnin S, Lagarde P, Terrier P, COindre JM, Aurias A. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics. J Pathol 2011; 223: 64–71

    Article  PubMed  CAS  Google Scholar 

  • Gieschen HL, Spiro I; Suit HD. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Phys 2001; 50: 127–131

    Article  CAS  Google Scholar 

  • Gisselsson D, Pettersson L, Hoglund M, Heidenblad M, Gorunova L, Liegant J, Mertens F, Dal Cin, Mitelman F, Mandahl N. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 2000; 97: 5357–5362

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, Mitelman F, Mertens F, Mandahl N. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 2001; 98: 12683–12688

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Glenn J, Sindelar WF, Kinsella T. Results of multimodality therapy of resectable soft tissue sarcomas of the retroperitoneum. Surgery 1985; 97: 316–324

    PubMed  CAS  Google Scholar 

  • Greene F, Page D Fleming I et al. (eds). AJCC Cancer Staging Manual, 6th edn. Heidelberg, Springer-Verlag 2002

    Book  Google Scholar 

  • Hanahan D, Weiberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70

    Article  PubMed  CAS  Google Scholar 

  • Hardell l, Sandstrom A. A case-control study: soft tissue sarcoma and exposure to phenoxyacetic acids or chlorophenols. Br J Cancer 1979; 39: 711–717

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Hassan I, Park SZ, Donohue JH, Nagorney DM, Kay PA, Nasciemento AG, Schleck CD, Ilstrup DM. Operative Management of primary retroperitoneal sarcomas. A reappraisal of an institutional experience. Ann Surg 2004; 239: 244–250

    Article  PubMed Central  PubMed  Google Scholar 

  • Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 1996; 96: 925–932

    Google Scholar 

  • Heinrich M, Corless C, Blanke c, Demetri GD, Joensuu H, van Mehren M, McGreevey LS, Wait CL, Griffith D, Chen C-J, Haley A, Kiese B, Druker B, Roberts P, Eisenberg B, Singer S, Silberman S, Dimitrijevic S, Fletcher CDM, Fletcher JA. KIT mutational status predicts clinical response to STI571 in patients with metastatic gastrointestinal tumors (GISTs). Prog Proc Am Soc Clin Oncol 2002; 21: 2a

    Google Scholar 

  • Heslin MJ, Lewis JJ, Nadler E et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997; 15: 2832–2839

    PubMed  CAS  Google Scholar 

  • Heslin MJ, Smith JK. Imaging of soft tissue sarcomas. Surg Oncol Clin N Am 1999; 8: 91–107

    PubMed  CAS  Google Scholar 

  • Ioannidis JPA, Lau J. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 2003; 44: 717–724

    PubMed  Google Scholar 

  • Israel-Mardirosian N, Adler LP. Positron emission tomography of soft tissue sarcomas. Curr Opin Oncol 2003; 15: 327–330

    Article  PubMed  Google Scholar 

  • Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft tissue sarcoma of the retro Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma. Analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 355–365

    Article  Google Scholar 

  • Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft tissue sarcoma of the retroperitoneum. Ann Surg 1990; 212: 51–59

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Jones DN, McCowage GB, Sostman HT, Brizel DM, Layfield L, Charles HC, Dewirst MW, Prescott DM, Friedman HS, Harrelson JM, Scully SP, Coleman RE. Monitoring of neoadjuvant therapy response of soft tissue and musculoskeletal sarcoma using fluorine-18 FDG PET. J Nucl Med 1996; 37: 1438–1444

    PubMed  CAS  Google Scholar 

  • Jones JJ, Catton CN, O´Sullivan B et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol 2002; 9: 346–354

    Article  PubMed  Google Scholar 

  • Karakousis CP, Kontzoglou K, Driscoll DL. Resectability of retroperitoneal sarcomas: a matter of surgical technique? Eur J Surg Oncol 1995; 21: 617–622

    Article  PubMed  CAS  Google Scholar 

  • Karakousis CP, Velez AF, Gerstenbluth R. Resectability and survival in retroperitoneal sarcomas. Ann Surg Oncol 1996; 3: 150–158

    Article  PubMed  CAS  Google Scholar 

  • Kattan MW, Leung DH, Brennan MF. Postoperative Nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20: 791–796

    Article  PubMed  Google Scholar 

  • Kilkenny JW, Bland KI, Copeland EM : Retroperitoneal sarcoma : the University of Florida experience. J Am Coll Surg 1996; 182: 329–339

    PubMed  Google Scholar 

  • Kransdorf MJ, Jelinek JS, Moser RP, Utz JA, Brower AC, Hudson TM, Berrey BH. Soft tissue masses: diagnosis using MR imaging. Am J Radiol 1989; 153: 541–547

    CAS  Google Scholar 

  • Kujath P, Bruch HP, Wünsch PH. Primär retroperitoneale Tumoren: Diagnose – Therapie – Prognose. Chirurg 1983; 54: 643–648

    PubMed  CAS  Google Scholar 

  • Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of saromas. Hum Pathol 2000; 31: 532–538

    Article  PubMed  CAS  Google Scholar 

  • Le Cesne A, Judson L, Crowther D, Rodenhuis S, Keizer HJ, Van Hoesel Q, Blay JY, Frisch J, Van Glabbeke M, Hermans C, Van Oosterom A, Tursz t, Verweji J. Randomized Phase III study comparing conventional dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stiumlating factor in advanced soft-tissue sarcomas: a trial of the European Organization for research and treatment of cancer Soft tissue and Bone Sarcoma Group. J Clin Oncol 2000; 18: 2676–2684

    PubMed  CAS  Google Scholar 

  • Lewis JJ, Leung DH, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 355–365

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Li FP; Fraumeni JF: Soft tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med 1969; 71: 747

    Google Scholar 

  • Mc Carville MB; Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005; 184: 1293–1304

    Article  Google Scholar 

  • Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res 2000; 462: 247–253

    Google Scholar 

  • Muller R, Hajdu SI, Brennan MF. Lymphangiosarcoma associated with chronic filarial lymphedema. Cancer 1987; 59: 179

    Article  PubMed  CAS  Google Scholar 

  • Norman RW, Mack FG, Award SA, Belitsky P, Schwarz RD, Lannon SG. Acute renal failure secondary to bilateral ureteric obstruction: review of 50 cases. J Urol 1983; 127: 601–604

    Google Scholar 

  • O´Sullivan B, Bell R, Bramwell V. Sarcoma of the soft tissues. In: R.L. Souhami, I. Tannock, P. Hohenberger and JC Horiot (eds), Oxford Textbook of Oncology, 2nd ed., pp. 2495–2523. Oxford: Oxford University Press, 2002

    Google Scholar 

  • Petersen IA;Haddock MG;Donahue JH. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002; 52: 469–472

    Google Scholar 

  • Pinson CW, ReMine SG, Fletcher WS, Braasch JW. Long-term results with primary retroperitoneal tumors. Arch Surg 1989; 124: 1168–1173

    Article  PubMed  CAS  Google Scholar 

  • Pisters P W, O´Sullivan B. Retroperiteoneal sarcomas: combined modality treatment approaches. Curr Opin Oncol 2002; 14: 400–405

    Article  PubMed  Google Scholar 

  • Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Cost-Effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer 2002; 94: 197–204

    Article  PubMed  Google Scholar 

  • Presant CA, Russel WO, Alexander RW, et al. Soft tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study group experience. J Clin Oncol 1986; 4: 1658–1661

    PubMed  CAS  Google Scholar 

  • Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E. Doxorubicin versus CYVADIC versus Doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcoma: a randomized study of the European organization for research and treatment of cancer soft tissue and bone sarcoma group. J Clin Oncol 1995; 13: 1537–1545

    PubMed  CAS  Google Scholar 

  • Sarcoma Meta-analysis collaboration. Adjuvant chemotherapy for localized resectable soft tissue sarcoma of adults: meta-analysis of individual data. The Lancet 1997; 350: 1647–1654

    Article  Google Scholar 

  • Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, Brinkschmidt C, van Valen F, Boecker W, Dockhorn-Dworniczak B, Poremba C. Alternative lengthening of telomeres is associated with chromosaml instability in osteosarcoms. Oncogene 2001; 20: 3825–3844

    Article  CAS  Google Scholar 

  • Schütte J, Hartmann JT, Reichardt P, Issels RD, Tunn PU, Budach V. Weichteilsarkome. Leitlinie der DGHO, Stand 2011

    Google Scholar 

  • Sergio G, Tenchini P, Nifosi E, Lacono C. Surgical strategy in primary retroperitoneal tumors. J Surg 1989: 76: 385–389

    Google Scholar 

  • Shapeero LG, Vanel D, Verstraete KL, Bloem, JL. Soft tissue sarcoma: fast magnetic resonance imaging with contrast for soft tissue sarcoma viability. Clin Orthop 2002; 397: 212–227

    Article  PubMed  Google Scholar 

  • Sharpless NE, Ferguson DO, O´Hagan RC, Castrillon DH, Lee C, Farazi PA, Alson S, Fleming J, Morton CC, Frank K, Chin L, Alt FW, DePinho RA. Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol Cell 2001; 8: 1187–1196

    Article  PubMed  CAS  Google Scholar 

  • Shibata D, Lewis JJ, leund DH, Brennan MF. Is there a role for incompete resection in the management of retroperitoneal liposarcomas ? J Am Coll Surg 2001; 193: 373–379

    Article  PubMed  CAS  Google Scholar 

  • Shiraki M, Enterline HT, Brooks JJ, et al. Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 1989; 64: 484–490

    Article  PubMed  CAS  Google Scholar 

  • Sindelar WF, Kinsella TJ, Chen PW. Intraoperative radiotherapy in retroperitoneal sarcomas: final results of a prospective, randomized, clinical trial. Arch Surg 1993; 128: 402–410

    Article  PubMed  CAS  Google Scholar 

  • Singer S. New diagnostic modalities in soft tissue sarcoma. Semin Surg Oncol 1999; 17: 11–22

    Google Scholar 

  • Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003; 238: 358–371

    PubMed Central  PubMed  Google Scholar 

  • Singer S, Brennan MF. Soft tissue sarcomas and bone tumors. In Surgery. Sabiston (eds.) Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 2004; 803–815

    Google Scholar 

  • Smith AH, Pearce NE, Fisher DO. Soft tissue sarcoma and exposure to phenoxyherbicides and chlorophenols in New Zealand. J Nat Cancer Inst 1984; 73: 1111

    PubMed  CAS  Google Scholar 

  • Sorensen SA, Mulvihill JJ, Nielsen A: Long term follow-up of von Recklinghausen neurofibromatosis: Survival and malignant neoplasms. N Engl J Med 1986; 314: 1010

    Article  PubMed  CAS  Google Scholar 

  • Stahl A, Wieder H, Wester HJ, Piert M, Lordick F, Ott K, Rummery E, Schwaiger M, Weber WA. PET/CT molecular imaging in abdominal oncology. Abdom Imaging 2004; 29: 388–397

    Article  PubMed  CAS  Google Scholar 

  • Sundaram M, Mc Guire MH, Herbold DR. Magnetic resonance imaging of soft tissue masses: an evaluation of 53 histological proven tumors. Magn Reson Imaging 1988; 6: 237–248

    Article  PubMed  CAS  Google Scholar 

  • Tomescu O, Barr FG. Chromosomal translocation in sarcomas: prospects for therapy. Trend Mol Med 2001; 7: 554–559

    Article  CAS  Google Scholar 

  • Tseng WH, Martinez SR, Do L, Tamurian RM, Borys D, Canter RJ. Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res 2011a; 168: 173–80

    Article  Google Scholar 

  • Tseng WH, Martinez SR; Tamurian RM, Chen SL, Bold RJ, Canter RJ. Contigous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol 2011b; 103: 390–4

    Article  Google Scholar 

  • Van de Rijn M, Barr FG, Xiong QB, Salhany KE. Fraker DL, Fisher C. Radiation-associated synovial sarcoma. Hum Pathol 1997; 28: 1325–1328

    Article  PubMed  CAS  Google Scholar 

  • van de Voorde L, Delrue L, van Eijkeren M, de Meerleer G. Radiotherapy and surgery – an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer 2011; 117: 4355–64

    Article  PubMed  Google Scholar 

  • Van Doorn RC, Gallee MP, Haart AA et al. Resectable retroperitoneal soft tissue sarcoma: the effect of extent of resection an postoperative radiation therapy on local tumor control. Cancer 1994; 73: 637–642

    Article  PubMed  Google Scholar 

  • Van Oosterom AT, Judsonn I, Verwiej J, Stroobants S, Donato di Paola E, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS. Safety and efficacy of imatinib [STI 571] in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 2001; 358: 1421–1423

    Article  PubMed  CAS  Google Scholar 

  • Walther PJ. Management of retroperitoneal sarcoma. In: DeKernion JB, Paulsen DF (eds) Genitourinary Cancer Management. Lea and Febiger, Philadelphia 1987, pp 271

    Google Scholar 

  • Wist E, Solheim P, Jacobsen AP, Blom P. Primary retroperitoneal sarcomas. Onc Copy 1985; 24: 305–310

    CAS  Google Scholar 

  • Wong S, Brennan MF. Therapeutisches Management intraabdomineller und retroperitonealer Weichgewebssarkome. Chirurg 2004; 75: 1174–1181

    Article  PubMed  CAS  Google Scholar 

  • Yoon SS; Duda DG, Karl DL, Kim TM, Kambadakone AR, Chen YL, Rothrock C, Rosenberg AE, Nielsen GP, Kirsch DG; Choy E, Harmon DC, Hornicek FJ, Dreyfuss J, Ancukiewicz M, Sahani DV, Park PJ, Jain RK, Delaney TF. Phase II study of neoadjuvant bevacizumab and radiotherapy for respectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2011; 81: 1081–90

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Zahm SG, Fraumeni JF. The epidemiology of soft tissue sarcoma. Semin Oncol 1997; 24: 504–524

    PubMed  CAS  Google Scholar 

  • Zhang G, Chen KK, Manivel C, Fraley EE. Sarcomas of the retroperitoneum and genitourinary tract. J Urol 1989; 141: 1107–1110

    PubMed  CAS  Google Scholar 

  • Ziran BH, Makley JT, Carter JR. Primary retroperitoneal sarcoms: common symptoms, common diagnoses, uncommon disease. Clin Orthop 1996; 331: 277–282

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Praxisklinik Urologie Rhein/Ruhr, Schulstraße 11, D-45468, Mühlheim a. d. Ruhr, Deutschland

    A. Eisenhardt

  2. Chefarzt der Abt. Onkologie/Hämatologie, Marienhospital Düsseldorf, Rochusstraße 2, D-40479, Düsseldorf, Deutschland

    H. J. Schütte

  3. Klinik für Strahlentherapie, Universitätsklinikum Essen, Hufelandstraße 55, D-45122, Essen, Deutschland

    M. Stuschke & G. Täger

Authors
  1. A. Eisenhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. J. Schütte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Stuschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Täger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Urologie, Universitätsklinikum Essen, Essen, Germany

    Herbert Rübben

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Eisenhardt, A., Schütte, H., Stuschke, M., Täger, G. (2014). Retroperitoneale Weichteiltumoren. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35032-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35032-0_27

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35031-3

  • Online ISBN: 978-3-642-35032-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation